face to face
“$100 BILLION TARGET IS
ACHIEVABLE BUT REQUIRES
HUGE COLLECTIVE EFFORT”
In an exclusive freewheeling conversation with the BioVoice News, Dr P M
Murali, President, Association of Biotechnology Led Enterprises, shared his
frank views on the target set up for the Indian biotech industry by 2025, current
startup ecosystem, issues that are holding us back, way forward and much
more. Read the detailed interview below:
BY RAHUL KOUL IN BENGALURU
DR PANCHAPAGESA MURALI IS THE
PRESIDENT OF THE ASSOCIATION OF
BIOTECHNOLOGY LED ENTERPRISES.
DR MURALI IS ALSO THE MANAGING
DIRECTOR AND CEO OF EVOLVA INDIA
SINCE SEPTEMBER 2006. HE HAS
OVER 25 YEARS OF EXPERIENCE IN
PHARMACEUTICAL AND HEALTHCARE
AREAS. HE HAS BEEN A SERIAL
ENTREPRENEUR FOR MORE THAN TWO
DECADES WITH MANY FIRST OF ITS
KIND PRODUCTS AND INNOVATIONS
IN MANY AREAS OF BIOTECHNOLOGY.
HE HAS ALSO BUILT PIONEERING
IT GREEN FIELD PROJECTS AND
WAS PART OF A VENTURE CAPITAL
ORGANIZATION TO EVALUATE
PROSPECTIVE TECHNOLOGIES FOR
COMMERCIALIZATION. HE RECEIVED
A PH.D. IN MICROBIOLOGY AND
MICROBIAL TECHNOLOGY FROM
MADURAI KAMARAJ UNIVERSITY.
10
BioVoiceNews | April 2017